- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07687550
Alterations in Spiking Following Muscle Fatigue in Volleyball Players
Alterations in Spiking Kinematic, Muscle Activation, and Subacromial Structures Following Muscle Fatigue in Volleyball Players
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Chi-Chong Lio
- Numéro de téléphone: 0965101633
- E-mail: liochichonggg@gmail.com
Lieux d'étude
-
-
-
Taipei, Taïwan, 112
- National Yang Ming Chiao Tung University
-
Contact:
- National Yang Ming Chiao Tung University
- Numéro de téléphone: (02)2826-7049
- E-mail: tshuang@nycu.edu.tw
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Between 18 and 35 years old
- At least 2 consecutive years of volleyball experience
- Involved in volleyball practice or game for at least 4 hours per week
- Able to perform a cross-body spike with 3-step
Exclusion Criteria:
- A history of major shoulder or spinal injury or surgery
- Experiencing shoulder pain (VAS ≥ 3/10) in the last 6 months
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Poor shoulder motor control
During shoulder medial rotation up to 60° in supine position, the scapula forward tilts or elevation occurs, difficulties in breathing, performing difficulties, unable to perform 60° medial rotation, glenohumeral anterior translation, fatigue, the need of external feedback and external support.
|
The subject performed upper extremity D2 diagonal exercise with Thera-band at kneeling position to simulate the arm movement of a volleyball spike. The movement is paced by a metronome at one beat per second, with one movement per beat. If participants could not keep up or become too fatigued, they are allowed to rest for 15 seconds before continuing. The subject was defined as fatigued, and the fatigue activity was stopped, only when all three of the following cumulative conditions were met:
|
|
Good shoulder motor control
During shoulder medial rotation up to 60° in supine position, no scapula and glenohumeral compensation, easy to breathing and perform 60° medial rotation without external feedback and external support.
|
The subject performed upper extremity D2 diagonal exercise with Thera-band at kneeling position to simulate the arm movement of a volleyball spike. The movement is paced by a metronome at one beat per second, with one movement per beat. If participants could not keep up or become too fatigued, they are allowed to rest for 15 seconds before continuing. The subject was defined as fatigued, and the fatigue activity was stopped, only when all three of the following cumulative conditions were met:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Degree of the glenohumeral and scapulothoracic joint during spiking
Délai: Baseline, immediately post-intervention (Day 1)
|
The kinematics is assessed using an electromagnetic motion tracking system (VIPERTM, Polhemus, USA) to measure the glenohumeral elevation, horizontal abduction/adduction, internal/external rotation, and scapulothoracic retraction/protraction, upward/downward rotation, anterior/posterior tilt during spiking movement. During the test, participants performed 3 times of cross-body spikes, with 15 seconds of rest between each trial. Data were collected at the end of the arm cocking (maximal shoulder horizontal abduction) and at ball-contact (maximal footswitch signal), and reported as mean values for each trial. (unit of measure: degree, °) |
Baseline, immediately post-intervention (Day 1)
|
|
Activation amplitude of the glenohumeral and periscapular muscles
Délai: Baseline, immediately post-intervention (Day 1)
|
The muscle activation amplitude of the serratus anterior, upper trapezius, lower trapezius, middle deltoid, infraspinatus, and pectoralis major during spiking movement. During the test, participants performed 3 times of cross-body spikes, with 15 seconds of rest between each trial. Data were collected in the arm cocking phase (from minimal shoulder elevation to the shoulder maximal horizontal abduction) and the acceleration phase (from maximal shoulder horizontal abduction to the ball-contact), and reported as mean values for each trial. (unit of measure: percentage, %) |
Baseline, immediately post-intervention (Day 1)
|
|
Mean power frequency of the glenohumeral and periscapular muscles
Délai: Baseline, immediately post-intervention (Day 1)
|
The mean power frequency of the serratus anterior, upper trapezius, lower trapezius, middle deltoid, infraspinatus, and pectoralis major during spiking movement. During the test, participants performed 3 times of cross-body spikes, with 15 seconds of rest between each trial. Data were collected in the arm cocking phase (from minimal shoulder elevation to the shoulder maximal horizontal abduction) and the acceleration phase (from maximal shoulder horizontal abduction to the ball-contact), and reported as mean values for each trial. (unit of measure: hertz, Hz) |
Baseline, immediately post-intervention (Day 1)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Acromio-humeral distance and thickness of supraspinatus tendon thickness during arm elevation
Délai: Baseline, immediately post-intervention (Day 1)
|
The subacromial structures is assessed using a diagnostic ultrasound system (SONIMAGE MX1 Ver. 1.10, Konica Minolta, Inc., Tokyo, Japan) to measure the acromio-humeral distance (AHD, from the lateral inferior edge of the acromion perpendicular to the humerus), supraspinatus tendon thickness (SST, from the subacromial-subdeltoid bursa perpendicular to the humerus), occupation ratio (OR, dividing SST by AHD). During the dynamic evaluation, participants performed 3 times of arm elevation to 90° and returning to the neutral position at scapular plane. During the static evaluation, participants performed 3 times of arm elevation to 60° at scapular plane. Data of dynamic evaluation is collected at 0° elevation and at the greater tuberosity of the humerus is aligned under the lateral inferior edge of the acromion. Data of static evaluation is collected at 0° elevation and 60° elevation. Data reported as mean values for each trial. (unit of measure: millimeter, mm) |
Baseline, immediately post-intervention (Day 1)
|
|
Degree of shoulder elevation at greater tuberosity-acromion alignment during arm elevation
Délai: Baseline, immediately post-intervention (Day 1)
|
The shoulder elevation angle is measured using a application software (Measure, Apple Inc., USA) at at greater tuberosity of humerus under Lateral inferior edge of the acromion, which assess diagnostic ultrasound system (SONIMAGE MX1 Ver.
1.10, Konica Minolta, Inc., Tokyo, Japan), and reported as mean values for each trial.
(unit of measure: degree, °).
|
Baseline, immediately post-intervention (Day 1)
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- NYCU114118AF
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .